These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9398176)

  • 1. An early step in Pseudomonas exotoxin action is removal of the terminal lysine residue, which allows binding to the KDEL receptor.
    Hessler JL; Kreitman RJ
    Biochemistry; 1997 Nov; 36(47):14577-82. PubMed ID: 9398176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of the glutamate residue of KDEL in increasing the cytotoxicity of Pseudomonas exotoxin derivatives and for increased binding to the KDEL receptor.
    Kreitman RJ; Pastan I
    Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):29-37. PubMed ID: 7717988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased cytotoxic activity of Pseudomonas exotoxin and two chimeric toxins ending in KDEL.
    Seetharam S; Chaudhary VK; FitzGerald D; Pastan I
    J Biol Chem; 1991 Sep; 266(26):17376-81. PubMed ID: 1910044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The KDEL retrieval system is exploited by Pseudomonas exotoxin A, but not by Shiga-like toxin-1, during retrograde transport from the Golgi complex to the endoplasmic reticulum.
    Jackson ME; Simpson JC; Girod A; Pepperkok R; Roberts LM; Lord JM
    J Cell Sci; 1999 Feb; 112 ( Pt 4)():467-75. PubMed ID: 9914159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of a potent chimeric toxin by replacement of domain III of Pseudomonas exotoxin with ricin A chain KDEL.
    Pitcher C; Roberts L; Fawell S; Zdanovsky AG; FitzGerald DJ; Lord JM
    Bioconjug Chem; 1995; 6(5):624-9. PubMed ID: 8974463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant immunotoxin containing a disulfide-stabilized Fv directed at erbB2 that does not require proteolytic activation.
    Kuan CT; Pastan I
    Biochemistry; 1996 Mar; 35(9):2872-7. PubMed ID: 8608123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The N-terminal region of the 37-kDa translocated fragment of Pseudomonas exotoxin A aborts translocation by promoting its own export after microsomal membrane insertion.
    Theuer CP; Buchner J; FitzGerald D; Pastan I
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7774-8. PubMed ID: 8356083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomonas exotoxin contains a specific sequence at the carboxyl terminus that is required for cytotoxicity.
    Chaudhary VK; Jinno Y; FitzGerald D; Pastan I
    Proc Natl Acad Sci U S A; 1990 Jan; 87(1):308-12. PubMed ID: 2104981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redirecting Pseudomonas exotoxin.
    FitzGerald D; Pastan I
    Semin Cell Biol; 1991 Feb; 2(1):31-7. PubMed ID: 1954341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Internalized Pseudomonas exotoxin A can exploit multiple pathways to reach the endoplasmic reticulum.
    Smith DC; Spooner RA; Watson PD; Murray JL; Hodge TW; Amessou M; Johannes L; Lord JM; Roberts LM
    Traffic; 2006 Apr; 7(4):379-93. PubMed ID: 16536737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Processing of Pseudomonas aeruginosa exotoxin A is dispensable for cell intoxication.
    Morlon-Guyot J; Méré J; Bonhoure A; Beaumelle B
    Infect Immun; 2009 Jul; 77(7):3090-9. PubMed ID: 19380469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated cleavage of Pseudomonas exotoxin between Arg279 and Gly280 generates the enzymatically active fragment which translocates to the cytosol.
    Ogata M; Fryling CM; Pastan I; FitzGerald DJ
    J Biol Chem; 1992 Dec; 267(35):25396-401. PubMed ID: 1460035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusions of anthrax toxin lethal factor to the ADP-ribosylation domain of Pseudomonas exotoxin A are potent cytotoxins which are translocated to the cytosol of mammalian cells.
    Arora N; Klimpel KR; Singh Y; Leppla SH
    J Biol Chem; 1992 Aug; 267(22):15542-8. PubMed ID: 1639793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational design of a chimeric toxin: an intramolecular location for the insertion of transforming growth factor alpha within Pseudomonas exotoxin as a targeting ligand.
    Kreitman RJ; Chaudhary VK; Siegall CB; FitzGerald DJ; Pastan I
    Bioconjug Chem; 1992; 3(1):58-62. PubMed ID: 1616950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-toxin hybrids directed to the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein exhibit lower toxicity than native Pseudomonas exotoxin.
    Zdanovsky AG; Zdanovskaia MV; Strickland D; FitzGerald DJ
    J Biol Chem; 1996 Mar; 271(11):6122-8. PubMed ID: 8626399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the carboxyl-terminal amino acids important for the ADP-ribosylation activity of Pseudomonas exotoxin A.
    Chow JT; Chen MS; Wu HC; Hwang J
    J Biol Chem; 1989 Nov; 264(31):18818-23. PubMed ID: 2553721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunotoxin with increased activity and homogeneity produced by reducing the number of lysine residues in recombinant Pseudomonas exotoxin.
    Debinski W; Pastan I
    Bioconjug Chem; 1994; 5(1):40-6. PubMed ID: 8199233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant single-chain immunotoxins against T and B cell leukemias.
    Kreitman RJ; Pastan I
    Leuk Lymphoma; 1994 Mar; 13(1-2):1-10. PubMed ID: 8025511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas exotoxin and recombinant immunotoxins derived from it.
    Fitzgerald D; Pastan I
    Ann N Y Acad Sci; 1993 Jun; 685():740-5. PubMed ID: 8363279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of sequences required for the cytotoxic action of a chimeric toxin composed of Pseudomonas exotoxin and transforming growth factor alpha.
    Kihara A; Pastan I
    Bioconjug Chem; 1994; 5(6):532-8. PubMed ID: 7873657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.